Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

Speier Introduces Bill to Curb Self-Referral of Imaging and Radiation Oncology

Representatives Jackie Speier (D-CA), Ways and Means Health Subcommittee Ranking Member Jim McDermott (D-WA) and Dina Titus (D-NV), recently introduced H.R. 2914, the Promoting Integrity in Medicare Act of 2013 (PIMA), in the House of Representatives.

Researchers use nano ‘SWAT team’ to bolster radiotherapy

Preliminary results of a pair of studies involving nanoparticles in cancer treatment have shown promising results for boosting the power of radiation therapy while preserving healthy tissue near tumors, according to research presented at the 55th Annual Meeting of the American Association of Physicists in Medicine in Indianapolis.

Urologists Discredit Flawed, Misleading GAO Cancer Treatment Utilization Study

The American Association of Clinical Urologists (AACU), the American Urological Association (AUA) and the Large Urology Group Practice Association (LUGPA), today jointly refuted the U.S. Government Accountability Office’s (GAO) flawed and misleading study on the use of intensity-modulated radiation therapy (IMRT) for the treatment of prostate cancer.

Cancer overdiagnosis: A path forward

As oncologists, radiologists and epidemiologists continue to debate the details of overdiagnosis and overtreatment, a viewpoint published online July 29 in JAMA listed several recommendations for the National Cancer Institute to consider as it attempts to evaluate the overdiagnosis issue.

USPSTF gives nod to CT lung cancer screening

The U.S. Preventive Services Task Force (USPSTF) has issued a Grade B recommendation for annual low-dose CT screening for individuals between the ages of 50 and 80 who are at high risk for lung cancer.

Sweden slashes low-risk prostate cancer imaging rates to 3 percent

A Swedish initiative to spur appropriate imaging use in prostate cancer by providing utilization data and guidelines to clinicians caused the rate of inappropriate scans for low-risk patients to nose-dive, according to a study published online July 23 in the Journal of the National Cancer Institute.

Alpha emitter targets prostate cancer bone metastases

Radium-223 dichloride, an alpha emitter that targets bone metastases, reduces risk of death by 30 percent for men with castration-resistant prostate cancer and bone metastases, according to a study published July 18 in The New England Journal of Medicine.

Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy

Elekta (NSE: EKTAb) and Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the Froedtert & The Medical College of Wisconsin Clinical Cancer Center (Milwaukee, Wisconsin) will join a consortium that is investigating the development of a magnetic resonance imaging (MRI) guided radiation therapy system.

Displaying 681 - 688 of 2554

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.